There was a decrease in the number of unique sites where phase 1 clinical trials for non-small cell lung cancer (NSCLC) were conducted between 2020 and 2024, according to a study presented at the ...

Nearly two-thirds of survivors are at least somewhat worried about disease recurrence, researchers reported at AACR 2026.

In this study, researchers examined the US federal cancer research funding landscape in relation to mortality across major cancer types.

Of more than 1,200 cancer patients and survivors surveyed in 2024, about 47% said they had carried medical debt.

More than 20% of cancer patients are affected by new-onset psychiatric conditions, researchers reported at the AACR Annual ...

Patients with cancer who use cannabis after diagnosis believe it helps with symptoms including pain, but are concerned about ...

Circulating tumor DNA (ctDNA) can be detected in plasma samples sometimes several years prior to a clinical diagnosis of cancer, according to research ...

(HealthDay News) — A new US Senate report, released by Sen. Bernie Sanders, found that drug companies involved in price deals with President Donald Trump have continued to raise prices on hundreds of ...

The multi-kinase inhibitor regorafenib did not improve overall survival (OS) compared with standard treatment for patients with newly diagnosed unmethylated or recurrent glioblast ...

A program that coupled mammograms with a lung cancer screening (LCS) awareness campaign led to increased LCS uptake in women at risk for lung cancer.

Decreases seen in the adjusted odds ratio of cancer over time; cancer risk higher for diffuse diseases of connective tissue versus RA ...

In this study, researchers aimed to examine survival outcomes with elraglusib plus chemotherapy compared to chemotherapy alone in untreated mPDAC.